解开秘密:脂肪组织功能障碍和动脉样硬化机制以及创新的治疗方法
Dana Bou Matar1, Muhammad Affan Elahi2, Hatouf Sukkarieh3
1Department of Physiology, College of Medicine, Alfaisal University, Riyadh, 11533, Saudi Arabia.
Atherosclerosis
|July 19, 2025
概括
脂肪组织功能障碍,以炎症和代谢变化为标志,导致动脉样硬化. 针对功能障碍的脂肪组织为心血管疾病的预防和治疗提供了新的策略.
科学领域:
- 心血管科学 心血管科学
- 代谢性疾病 代谢性疾病
- 内分泌学 在内分泌学.
背景情况:
- 脂肪组织对于能量平衡和激素调节至关重要.
- 与肥胖和炎症相关的功能障碍脂肪组织,有助于动脉样硬化.
- 本综述探讨了各种脂肪储存在代谢和血管健康中的作用.
研究的目的:
- 探索脂肪组织功能障碍和动脉样硬化之间的复杂联系.
- 阐明脂肪组织对血管疾病的内分泌,炎症和代谢贡献.
- 审查针对心血管疾病 (CVD) 管理的脂肪组织功能障碍的新型治疗策略.
主要方法:
- 关于脂肪组织生物学和动脉样硬化的综合文献综述.
- 分析白色,棕色,色和周血管脂肪组织的不同作用.
- 评估最近脂肪细胞线粒体功能和治疗干预措施的进展.
主要成果:
- 脂肪组织功能障碍,包括改变的脂素分泌和炎症,促进血管损伤.
- 白色脂肪组织功能障碍加剧了胰岛素抵抗和脂质失调.
- 功能障碍的棕色/色脂肪组织会损害热生成和脂质清除,而周围血管脂肪组织 (PVAT) 在肥胖中变得有炎症作用.
结论:
- 脂肪组织功能障碍是通过代谢和炎症途径导致动脉样硬化的关键驱动因素.
- 向脂肪细胞线粒体功能,PVAT,并促进脂肪色是有希望的治疗途径.
- 了解脂肪组织的作用对于开发有效的心血管疾病预防和治疗策略至关重要.
相关概念视频
Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
Atherosclerosis I: Introduction
89
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
89
Peripheral Artery Disease III: Interprofessional Care
30
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
30
Overview of Lipid Metabolism
2.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.5K
Coronary Artery Disease I: Introduction
59
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
59


